These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22094993)

  • 41. Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis.
    Rivard JD; Temple WJ; McConnell YJ; Sultan H; Mack LA
    Am J Surg; 2014 May; 207(5):760-4; discussion 764-5. PubMed ID: 24791641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of stomach peritoneal infiltration in colorectal cancer using PET-FDG.
    Domínguez Grande ML; Bueno JG; Fernández JP; Suárez AM; Zomeño M; Oromendía AO; Kosvintseva O; Pozo MA
    Clin Nucl Med; 2005 Feb; 30(2):122-3. PubMed ID: 15647685
    [No Abstract]   [Full Text] [Related]  

  • 43. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
    Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
    Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
    Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Value of PET/CT imaging for diagnosing pulmonary metastasis of colorectal cancer.
    Bamba Y; Itabashi M; Kameoka S
    Hepatogastroenterology; 2011; 58(112):1972-4. PubMed ID: 22024070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT.
    Rakheja R; Makis W; Hickeson M
    Abdom Imaging; 2012 Apr; 37(2):304-8. PubMed ID: 21394599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical value of (18)F-FDG PET/CT in postoperative monitoring for patients with colorectal carcinoma.
    Han A; Xue J; Zhu D; Zheng J; Yue J; Yu J
    Cancer Epidemiol; 2011 Oct; 35(5):497-500. PubMed ID: 21296635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The value of 18F-FDG positron emission tomography/computed tomography on the pre-operative staging and the management of patients with pancreatic carcinoma.
    Wang XY; Yang F; Jin C; Guan YH; Zhang HW; Fu DL
    Hepatogastroenterology; 2014 Oct; 61(135):2102-9. PubMed ID: 25722999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of FDG-PET/CT for peritoneal carcinomatosis before hyperthermic intraperitoneal chemotherapy.
    Berthelot C; Morel O; Girault S; Verrièle V; Poirier AL; Moroch J; Boucher Y; Le Jeune JJ; Lorimier G
    Nucl Med Commun; 2011 Jan; 32(1):23-9. PubMed ID: 21042225
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Malignant tumor with false negative 18F-FDG PET image].
    Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
    Lee JH; Park SG; Jee KN; Park DG; Namgung H; Song IH
    Nucl Med Commun; 2010 Jun; 31(6):576-82. PubMed ID: 20216474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterizing omental PET/CT findings for differentiating tuberculous peritonitis from peritoneal carcinomatosis.
    Duan H; Xu D; Lu R; Wang S; Xie R; Wang S
    Abdom Radiol (NY); 2021 Dec; 46(12):5574-5585. PubMed ID: 34549331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging.
    Panagiotidis E; Datseris IE; Exarhos D; Skilakaki M; Skoura E; Bamias A
    Nucl Med Commun; 2012 Apr; 33(4):431-8. PubMed ID: 22293498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of cardiophrenic angle lymph node for the diagnosis of colorectal peritoneal carcinomatosis.
    Caramella C; Pottier E; Borget I; Malka D; Goéré D; Boige V; Honoré C; Dartigues P; Dumont F; Ducreux M; Elias D; Dromain C
    Eur J Cancer; 2013 Dec; 49(18):3798-805. PubMed ID: 23899531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    de Bree E; Koops W; Kröger R; van Ruth S; Verwaal VJ; Zoetmulder FA
    Eur J Surg Oncol; 2006 Feb; 32(1):65-71. PubMed ID: 16290055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
    Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
    Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.